Austrian Breast & Colorectal Cancer Study Group
Austria's academic breast and colorectal trials group, whose bone-targeted and extended endocrine therapy trials changed breast cancer practice.
Founded in 1984, ABCSG runs academic trials through Austria's hospitals and partners with the Breast International Group and the US groups on global studies. ABCSG-12 (zoledronic acid with ovarian suppression in premenopausal breast cancer) and ABCSG-18 (adjuvant denosumab) made bone-targeted agents part of adjuvant care, and ABCSG-16 defined how long extended aromatase inhibitor therapy should last. It co-led PALLAS, the adjuvant palbociclib trial, with Alliance Foundation Trials and BIG. Colorectal and pancreatic trials run through the same network.
- Adjuvant endocrine and bone-targeted therapy (ABCSG-12, -16, -18)
- PALLAS (adjuvant palbociclib, with Alliance and BIG)
- Colorectal and pancreatic cancer trials
Pages like this
not linked directly; found by shared links- InstitutionComprehensive Cancer Center Vienna – Medical University of Vienna / AKH
Shares Breast International Group (BIG), Palbociclib, CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs).
- InstitutionGEICAM Spanish Breast Cancer Group
Shares Breast International Group (BIG), Palbociclib, CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs).
- InstitutionSOLTI Cancer Research Group
Shares Breast International Group (BIG), Palbociclib, CDK4/6 inhibitors, HER2-positive breast cancer.
- PairingCDK4/6 inhibitor + endocrine therapy
Shares Palbociclib, CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs), HR-positive / HER2-negative breast cancer.
- InstitutionEdinburgh Cancer Centre / CRUK Scotland Centre
Shares Breast International Group (BIG), CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs), HR-positive / HER2-negative breast cancer.
- InstitutionETOP IBCSG Partners Foundation
Shares Alliance for Clinical Trials in Oncology, Breast International Group (BIG), Endocrine therapy (SERMs, AIs, SERDs), HER2-positive breast cancer.
- InstitutionInstituto Alexander Fleming
Shares Palbociclib, HER2-positive breast cancer, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionNSABP Foundation
Shares German Breast Group (GBG), Endocrine therapy (SERMs, AIs, SERDs), HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.